Literature DB >> 21472099

Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

Jay Pravda1.   

Abstract

Crohn's disease (CD) is a chronic inflammatory bowel disease. Research has identified genetic predisposition and environmental factors as key elements in the development of the disease. However, the precise mechanism that initiates immune activation remains undefined. One pathway for luminal antigenic molecules to enter the sterile lamina propria and activate an immune response is via transcytosis. Transcytosis, although tightly regulated by the cell, has the potential for transepithelial transport of bacteria and highly antigenic luminal molecules whose uncontrolled translocation into the lamina propria can be the source of immune activation. Viewed as a whole, the evidence suggests that unregulated intestinal epithelial transcytosis is involved in the inappropriate presentation of immunogenic luminal macromolecules to the intestinal lamina propria. Thus fulfilling the role of an early pre-morbid mechanism that can result in antigenic overload of the lamina propria and initiate an immune response culminating in chronic inflammation characteristic of this disease. It is the aim of this paper to present evidence implicating enterocyte transcytosis in the early etio-pathogenesis of CD.

Entities:  

Keywords:  Crohn’s; Endocytosis; Transcytosis

Mesh:

Year:  2011        PMID: 21472099      PMCID: PMC3070014          DOI: 10.3748/wjg.v17.i11.1416

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  118 in total

Review 1.  Systematic review: has disease outcome in Crohn's disease changed during the last four decades?

Authors:  F L Wolters; M G V M Russel; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

Review 2.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

3.  Studies on peroxisomes of colonic mucosa in Crohn's disease.

Authors:  I Aimone-Gastin; S Cable; J M Keller; M A Bigard; B Champigneulle; P Gaucher; J L Gueant; M Dauça
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

Review 4.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Authors:  Martin Feller; Karin Huwiler; Roger Stephan; Ekkehardt Altpeter; Aijing Shang; Hansjakob Furrer; Gaby E Pfyffer; Thomas Jemmi; Andreas Baumgartner; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

5.  Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.

Authors:  Anne Hegarty; Tim Hodgson; Stephen Porter
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2003-05

6.  Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease.

Authors:  Tim J Bull; Elizabeth J McMinn; Karim Sidi-Boumedine; Angela Skull; Damien Durkin; Penny Neild; Glenn Rhodes; Roger Pickup; John Hermon-Taylor
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 7.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

8.  Intestinal alkaline phosphatase: selective endocytosis from the enterocyte brush border during fat absorption.

Authors:  Gert H Hansen; Lise-Lotte Niels-Christiansen; Lissi Immerdal; Birthe T Nystrøm; E Michael Danielsen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-18       Impact factor: 4.052

Review 9.  Contamination of food products with Mycobacterium avium paratuberculosis: a systematic review.

Authors:  M M Eltholth; V R Marsh; S Van Winden; F J Guitian
Journal:  J Appl Microbiol       Date:  2009-03-30       Impact factor: 3.772

Review 10.  Endocytosis unplugged: multiple ways to enter the cell.

Authors:  Sudha Kumari; Swetha Mg; Satyajit Mayor
Journal:  Cell Res       Date:  2010-02-02       Impact factor: 25.617

View more
  4 in total

Review 1.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.

Authors:  S C Nalle; J R Turner
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

Review 2.  Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.

Authors:  Susana Lechuga; Andrei I Ivanov
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-03-18       Impact factor: 4.739

Review 3.  Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.

Authors:  Ali Shawki; Declan F McCole
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-10-22

Review 4.  Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation.

Authors:  Rosa Direito; João Rocha; Bruno Sepodes; Maria Eduardo-Figueira
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.